Brief: Hoth Therapeutics Announces Positive Findings On GDNF's Potential As A Game-Changer In Obesity Treatment And Reduced Fatty Liver Disease
04/03/2025 14:09
March 4 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS ANNOUNCES POSITIVE FINDINGS ON GDNF'S POTENTIAL AS A GAME-CHANGER IN OBESITY TREATMENT AND REDUCED FATTY LIVER DISEASE Source text: ID:nPn8zGxcca Further company coverage: HOTH.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology